Check-out the new submission category at CTAD: Clinical Trials Early Career Investigator Showcase  

New platform at #CTAD24 for early-career investigators to showcase their research in AD/ADRD!   

Read more here  ctad-alzheimer.com/clinical-trial…

New submission category at CTAD: Clinical Trials Early Career Investigator Showcase  

This is a platform at CTAD for early-career investigators to showcase their research in AD/ADRD!   

Read more here  ctad-alzheimer.com/clinical-trial…

New submission category at #CTAD24 : Clinical Trials Early Career Investigator Showcase  
Great opportunity for early-career investigators to showcase their research in AD/ADRD!   
Learn more here  ctad-alzheimer.com/clinical-trial…

Press release: BioArctic and Eisai sign research evaluation agreement regarding a potential new treatment combining BioArctic’s proprietary BrainTransporter™ technology with an undisclosed Alzheimer drug candidat. bioarctic.se/en/bioarctic-a…

DAC has partnered with Scientific American to produce a special issue focused on Alzheimer's disease, featuring contributions from Bill Gates, former NIH director Elias Zerhouni, and other incredible global health and aging leaders. Find the full issue here:

scientificamerican.com/custom-media/t…

Association between Resting Heart Rate and Machine Learning-Based Brain Age in Middle- and Older-Age. Wang, J., et al. 
doi.org/10.14283/jpad.…
#Brain #OlderAge

Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment | The Journal of Prevention of Alzheimer's Disease link.springer.com/article/10.142…

Join us in Madrid on October 29 – November 1, 2024!
Secure your in-person registration today
secure.key4events.com/key4register/c… 

#Alzheimers #research #therapeutics #drugdevelopment

Do not miss the chance to present your work on Alzheimer’s Disease Clinical Trials in Madrid!
Discover our different submission categories and topics.
Deadline to submit: June 4, 2024
ctad-alzheimer.com/call-abstracts…

#Alzheimers #research #therapeutics #drugdevelopment

Join us in Madrid on October 29 – November 1, 2024!
Secure your in-person registration today
secure.key4events.com/key4register/c… 

#Alzheimers #research #therapeutics #drugdevelopment

Do not miss the chance to present your work on Alzheimer’s Disease Clinical Trials in Madrid!
Discover our different submission categories and topics.
Deadline to submit: June 4, 2024
ctad-alzheimer.com/call-abstracts…

#Alzheimers #research #therapeutics #drugdevelopment

Request for Information: NIH Office of Data Science Strategy seeks public input on Proposed Use of Common Data Elements (CDEs) for NIH-Funded Clinical Research and Trials | Closing date for responses: April 20, 2024: datascience.nih.gov/cde-rfi

Countering brain decline in old individuals in 'Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche.' Nat Aging (2024). doi.org/10.1038/s43587… Bruno Vellas Isabelle ADER Philippe Valet Infinity Toulouse I2MC-Toulouse Laure Rouch

Microglia expressing the inhibitory receptor LILRB4 laze around plaques in #Alzheimersdisease and amyloidosis mice. An antibody against LILRB4 stirred microglia to engulf Aβ fibrils and lower plaque load. Washington University in St. Louis ow.ly/7zvU50RexJh

Insightful keynote presentations at #CTAD24 !
Discover our speakers at the forefront of Alzheimer's Disease research and care.
ctad-alzheimer.com/keynotes

Registrations for #CTAD24 are open!
Don't miss this chance to join leading experts and researchers in the fight against Alzheimer's. Secure your spot today and be part of the groundbreaking discussions and advancement in drug development!
ctad-alzheimer.com/registrations-1

New publication from @I2MCT and IHU HealthAge Team in Toulouse at INSPIRE Platform - IHU HealthAge 'Targeting Gi-coupled P2Y13 receptor in adipose tissue may help combat age-associated metabolic disorders, including #diabetes and liver diseases #MASLD .'
insight.jci.org/articles/view/…
Martinez Laurent

Discover our lineup of keynote speakers for #CTAD24 ! Dive into cutting-edge research and insights at the forefront of Alzheimer's treatment and care.

ctad-alzheimer.com/keynotes

Registrations for #CTAD24 are open!

Don't miss this chance to join leading experts and researchers in the fight against Alzheimer's. Secure your spot today and be part of the groundbreaking discussions and advancement in drug development!
ctad-alzheimer.com/registrations-1

👏Great launch for the IHU HealthAge Toulouse by its founder Professor Bruno Vellas #healthylongevity #geroscience INSPIRE Platform - IHU HealthAge UT3 Paul Sabatier CHU de Toulouse Inserm Occitanie Méditerranée